Juneja Amandeep, Wang David E, Whitaker Litton, Hoffstaetter Tabea, Silpe Jeffrey, Landis Gregg S, Etkin Yana
Nuvance Health, Danbury, CT, USA.
Northwell, New Hyde Park, NY, Department of Surgery at Zucker School of Medicine, Manhasset, NY, USA.
J Vasc Access. 2025 Jul;26(4):1265-1271. doi: 10.1177/11297298241266668. Epub 2024 Aug 16.
Balloon-assisted maturation (BAM) is a well-established technique for maturation of inadequate arteriovenous fistulas (AVF). The objective of this study was to evaluate outcomes of initial BAM using large-diameter angioplasty balloons.
Charts of patients who underwent BAM between 2018 and 2021 at a single academic institution were reviewed. AVF maturation rate was the primary outcome. Secondary outcomes included procedural complications, re-intervention rates, post-procedure vein diameter, and time to catheter-free hemodialysis (HD). Outcomes of patients that underwent initial BAM with ⩾7 mm diameter balloons (Group I) were compared to those of patients that had initial BAM with <7 mm balloons (Group II).
Group I ( = 149) was a significantly younger cohort and had more men compared to Group II ( = 90). There were no significant differences associated with procedural details and complication rates. Median vein diameter was larger (5.9 mm, IQR: 5-6.4) in Group I compared to Group II (5.1 mm, IQR: 4.2-5.9; = 0.03) on post-procedure Duplex ultrasound. There was also a higher incidence of vein stenosis in Group II. The overall maturation rate was higher in Group I (97% vs 88%, = 0.003), and a larger proportion of patients in Group II required more than one BAM to achieve maturation (33% vs 16%, = 0.002). The median time to catheter-free HD after first BAM was 29 days (IQR: 19-47) in Group I and 42 days (IQR: 24-75) in Group II ( = 0.002). At 60 days after first BAM, the incidence of catheter-free HD was 83% in Group I versus 67% in Group II ( = 0.001).
Our study demonstrates that the ability to utilize large angioplasty balloons during initial BAM is associated with higher rates of AVF maturation with fewer re-interventions and shorter time to catheter-free dialysis. AVFs that can tolerate this procedure often have more favorable baseline characteristics.
球囊辅助成熟术(BAM)是一种成熟的用于使不充分动静脉内瘘(AVF)成熟的技术。本研究的目的是评估使用大直径血管成形术球囊进行初次BAM的效果。
回顾了2018年至2021年在单一学术机构接受BAM治疗的患者病历。AVF成熟率是主要结局指标。次要结局指标包括手术并发症、再次干预率、术后静脉直径以及无导管血液透析(HD)的时间。将最初使用直径≥7mm球囊进行BAM的患者(第一组)的结局与最初使用直径<7mm球囊进行BAM的患者(第二组)的结局进行比较。
与第二组(n = 90)相比,第一组(n = 149)患者队列明显更年轻,男性更多。在手术细节和并发症发生率方面没有显著差异。术后双功超声检查显示,第一组的中位静脉直径更大(5.9mm,四分位间距:5 - 6.4),而第二组为(5.1mm,四分位间距:4.2 - 5.9;P = 0.03)。第二组静脉狭窄的发生率也更高。第一组的总体成熟率更高(97%对88%,P = 0.003),并且第二组中需要不止一次BAM才能实现成熟的患者比例更高(33%对16%,P = 0.002)。第一组首次BAM后无导管HD的中位时间为29天(四分位间距:19 - 47),第二组为42天(四分位间距:24 - 75)(P = 0.002)。在首次BAM后60天,第一组无导管HD的发生率为83%,而第二组为67%(P = 0.001)。
我们的研究表明,在初次BAM期间使用大血管成形术球囊的能力与更高的AVF成熟率、更少的再次干预以及更短的无导管透析时间相关。能够耐受该手术的AVF通常具有更有利的基线特征。